TJ301 300mg

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03235752 (ClinicalTrials.gov)	February 6, 2018	28/7/2017	Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis	A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy o ...	Active Ulcerative Colitis	Drug: TJ301 300mg;Drug: TJ301 600mg;Drug: Placebo	I-Mab Biopharma HongKong Limited	NULL	Recruiting	18 Years	70 Years	All	90	Phase 2	Australia;China;Korea, Republic of;Taiwan

First Previous1Next Last